MSD’s investigational KRAS G12C inhibitor has shown signs of anti-tumour activity when used both alone and in combination ...

Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Louisville MSD customers in Jefferson and Oldham counties could see higher prices starting in Summer 2025.

Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...

Jefferson and Oldham county residents will see their MSD bills go up again this year. MSD announced on Tuesday that the board ...

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...

The Louisville MSD Board approved a preliminary rate increase Tuesday, saying it's going to protect public health, property ...

There will now be a 30-day comment period and the board will vote on the final rate resolution on July 28, with the rates taking effect for Jefferson County on Aug. 1, if approved.

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

Louisville MSD board members voted to approve a preliminary rate increase. If approved, the rate increase would add $3.91 to the average monthly bill for customers in Jefferson County and $1.57 ...